{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:57Z","timestamp":1789924797116,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jneuroim.2012.05.011","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T02:32:03Z","timestamp":1339209123000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine"],"prefix":"10.1016","volume":"250","author":[{"given":"Konstantinos","family":"Poulas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euphrosyni","family":"Koutsouraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kordas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kokla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.05.011_bb0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-89-6-939","article-title":"Ptosis and weakness after start of d-penicillamine therapy","volume":"89","author":"Atcheson","year":"1978","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2012.05.011_bb0010","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/j.1875-9114.1997.tb03085.x","article-title":"Drug-induced neuromuscular blockade and myasthenia gravis","volume":"17","author":"Barrons","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.1.5958.600","article-title":"Myasthenia gravis associated with penicillamine treatment of rheumatoid arthritis","volume":"1","author":"Bucknall","year":"1975","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0020","series-title":"Myasthenia Gravis and Related Disorders","first-page":"53","article-title":"Immunopathogenesis of myasthenia gravis","author":"Conti-Fine","year":"2003"},{"issue":"46","key":"10.1016\/j.jneuroim.2012.05.011_bb0025","first-page":"2336","article-title":"Myasthenia induced by d-penicillamine. Study of immuno-clinical correlations in 23 cases","volume":"14","author":"D'Anglejan","year":"1985","journal-title":"Presse Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1445-5994.1979.tb03383.x","article-title":"Penicillamine: friend or foe?","volume":"9","author":"Dawkins","year":"1979","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM197902083000602","article-title":"Reduction of immune complexes and immunoglobins induced by d-penicillamine in primary biliary cirrhosis","volume":"300","author":"Epstein","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1740-2557-5-1","article-title":"Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases","volume":"5","author":"Fridkis-Hareli","year":"2008","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-87-5-578","article-title":"d-penicillamine induced myasthenia gravis in rheumatoid arthritis","volume":"87","author":"Gordon","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-61-3-556","article-title":"Rheumatoid arthritis with arteritis: report of a case treated with d-penicillamine","volume":"61","author":"Jaffe","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0060","series-title":"Penicillamine Research in Rheumatoid Disease","first-page":"11","article-title":"Penicillamine treatment of rheumatoid arthritis. Rationale, pattern of clinical response and clinical pharmacology and toxicology","author":"Jaffe","year":"1976"},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bjo.73.12.1015","article-title":"Ocular myasthenia gravis after d-penicillamine administration","volume":"73","author":"Katz","year":"1989","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0076-6879(81)74031-X","article-title":"Production and assay of antibodies to acetylcholine receptors","volume":"74","author":"Lindstrom","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0080","series-title":"Penicillamine Research in Rheumatoid Disease","first-page":"172","article-title":"d-penicillamine and lymphocyte function in rheumatoid arthritis: the inhibitory and augmenting effects of d-penicillamine in vitro on phytohemagglutinin-induced lymphocyte transformation","author":"Main","year":"1976"},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0002-9343(77)90153-X","article-title":"Penicillamine associated myasthenia gravis antiacetylcholine receptor and antistriational antibodies","volume":"63","author":"Masters","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0090","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2012.05.011_bb0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-1331.2006.01214.x","article-title":"Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK\u2212 patients","volume":"13","author":"Padua","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1405.002","article-title":"Myasthenia gravis experimentally induced with muscle-specific kinase","volume":"1132","author":"Shigemoto","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.05.011_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4103\/0028-3886.68687","article-title":"Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient","volume":"58","author":"Suhail","year":"2010","journal-title":"Neurol. India"},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2011.09.007","article-title":"Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis","volume":"240\u2013241","author":"Trakas","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of MuSK myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0125","first-page":"80","article-title":"Fine antigenic specificities of antibodies in sera from patiens with d-Penicillamine-induced myasthenia gravis","volume":"74","author":"Tzartos","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2012.05.011_bb0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:20:35Z","timestamp":1759047635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0165572812001658"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.05.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}